India, June 30 -- image credit- shutterstock

The Trump administration is at it again and after the pharma tariff saga, the US President has signed a wide-reaching executive order (EO) on May 12. The EO directs drugmakers to lower the prices of medicines to align with what other countries pay. The price cut range may be from 30 to 80 per cent. Drugmakers are required to make the price changes within a month from the date of issuance of the order, failing which, punitive action would be taken. This is all part of the so-called Most Favoured Nation (MFN) pricing framework by the US that has set alarm bells ringing.

The US pays the highest prices for prescription drugs, sometimes nearly three times more than other developed nations.

Impact...